ACTU (Actuate Therapeutics) Book Value per Share: $0.16 (As of Mar. 2026)

What is Actuate Therapeutics Book Value per Share?

Actuate Therapeutics ACTU -4.64% 14 Book Value per Share is $0.16 as of Mar. 2026. GuruFocus rates ACTU with a GF Score™ of 14/100.

Actuate Therapeutics's book value per share for the quarter that ended in Mar. 2026 was $0.16.

During the past 12 months, Actuate Therapeutics's average Book Value Per Share Growth Rate was 6720.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Actuate Therapeutics's current price is $1.43. Its book value per share for the quarter that ended in Mar. 2026 was $0.16. Hence, today's PB Ratio of Actuate Therapeutics is 8.94.

During the past 4 years, the highest P/B Ratio of Actuate Therapeutics was 9.63. The lowest was 0.00. And the median was 0.00.

Actuate Therapeutics (NAS:ACTU) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Actuate Therapeutics Book Value per Share Related Terms

Actuate Therapeutics Book Value per Share Historical Data

* Premium members only.

The historical data trend for Actuate Therapeutics's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actuate Therapeutics Book Value per Share Chart

Actuate Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Dec25

Book Value per Share

-3.94

-5.21

0.01

0.34

Actuate Therapeutics Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Book Value per Share	Get a 7-Day Free Trial									-0.26	-0.13	0.47	0.34	0.16

ACTU vs RNXT, ESLA, APLM: Book Value per Share Comparison

For the Biotechnology subindustry, Actuate Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actuate Therapeutics PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actuate Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Actuate Therapeutics's PB Ratio falls into.

Save Embed

14GF Score

Actuate Therapeutics Inc ACTU

Book Value per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Actuate Therapeutics Book Value per Share Calculation

Actuate Therapeutics's Book Value Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7.92	-	0.00)	/	23.25
	=	0.34

Actuate Therapeutics's Book Value Per Share for the quarter that ended in Mar. 2026 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3.78	-	0.00)	/	23.71
	=	0.16

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →

What does a Book Value per Share of $0.16 mean?

Actuate Therapeutics (ACTU) has a Book Value per Share of $0.16 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Actuate Therapeutics and its competitors.

Is Actuate Therapeutics' Book Value per Share too high?

Actuate Therapeutics' current Book Value per Share is $0.16. Overall, Actuate Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.

How does Actuate Therapeutics' Book Value per Share compare to RNXT and ESLA?

Actuate Therapeutics' Book Value per Share of $0.16 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Book Value per Share for a Biotechnology company?

A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Book Value per Share mean?

A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Actuate Therapeutics and its competitors. Actuate Therapeutics's current Book Value per Share is $0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Actuate Therapeutics stock overvalued right now?

Actuate Therapeutics (ACTU) has a current Book Value per Share of $0.16. The current Book Value per Share is $0.16. Actuate Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Book Value per Share calculated?

Book Value per Share is calculated from a company's financial statements. For Actuate Therapeutics (ACTU), the current Book Value per Share is $0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Actuate Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies RNXT ESLA APLM ELOX HYPD MGX KALA ABVC VERU GRCE VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 1751 River Run, Suite 400, Fort Worth, TX, USA, 76107

Website https://www.actuatetherapeutics.com

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

14GF Score

Get the complete analysis for ACTU

Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.43

Price

View ACTU Analysis

See Book Value per Share data for all stocks →